Publications by authors named "L B Zimmerhackl"

Claim this Profile
N
Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab.
Magdalena Riedl, Johannes Hofer, Thomas Giner, Alejandra Rosales, Karsten Häffner, Lothar B Zimmerhackl

J Immunol Methods· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
C M Legendre, C Licht, P Muus, L A Greenbaum, S Babu, L B Zimmerhackl

N Engl J Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
Johannes Hofer, Andreas R Janecke, L B Zimmerhackl, Magdalena Riedl, Alejandra Rosales

Clin J Am Soc Nephrol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.
Manuela Zlamy, Johannes Hofer, Johannes Elias, Ulrich Vogel, Matthias Frosch, Lothar Bernd Zimmerhackl

Pediatr Transplant· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae.
Alejandra Rosales, Johannes Hofer, Lothar-Bernd Zimmerhackl, Therese C Jungraithmayr, Magdalena Riedl

Clin Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis